New chemo strategy aims to outsmart aggressive myeloma
NCT ID NCT00869232
First seen May 25, 2026 · Last updated May 25, 2026
Summary
This study tests a different way of giving chemotherapy to people with a high-risk form of multiple myeloma. Instead of high doses with long breaks, patients get lower doses of several drugs in shorter cycles. The goal is to keep the cancer from growing back between treatments, leading to longer remissions and better survival. About 90 newly diagnosed patients with high-risk features will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Conditions
Explore the condition pages connected to this study.